Clinical Trials Browser

Phase 3 × INDUSTRY × iptacopan × Clear all

NCT06517758 2026-02-24

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

Phase 3 Recruiting

Myasthenia Gravis